Evaluation of Patient's Knowledge of Their NACO Treatment
NCT03323320 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51
Last updated 2018-02-27
Summary
More than one million of patient receive anti vitamine K treatment which is the main cause of hospitalization. About 50 000 patient receive direct oral anticoagulant .
The aim is to evaluate the patient's level of knowledge about their anticoagulant treatment and specially about the side effect
Conditions
- Anticoagulant
Sponsors & Collaborators
-
Fondation Hôpital Saint-Joseph
lead OTHER
Principal Investigators
-
Romain CADOR, MD · GHPSJ
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-12-05
- Primary Completion
- 2017-03-31
- Completion
- 2017-11-01
Countries
- France
Study Locations
More Related Trials
-
Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.
NCT05928091 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Development of a Questionnaire to Assess Patient Knowledge About Non-vitamin K Anticoagulants (NOAC)
NCT03124654 ·Status: COMPLETED
-
Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 80 Years and Over
NCT02286414 ·Status: COMPLETED
-
Pilot Study: Comparison of Patients' Knowledge of Direct Oral Anticoagulants in Post-hospitalization Between 2 Cardiology Departments Offering or Not a Pharmaceutical Interview During Hospitalization
NCT04674202 ·Status: UNKNOWN
-
Anticoagulant Clinics and Vitamin K Antagonists
NCT00966290 ·Status: COMPLETED ·Phase: PHASE4
-
Education Program for Patients Receiving Oral Anticoagulation
NCT01339611 ·Status: UNKNOWN ·Phase: NA
-
Cohort of Patients With Left Ventricular Thrombus: Management and Outcomes in the Direct Oral Anticoagulants Era
NCT05028777 ·Status: RECRUITING
-
Balancing of Patients Treated by Vitamin K Antagonists (VKAS) in General Medicine
NCT03914053 ·Status: COMPLETED
-
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Concentration and Clinical Outcomes.
NCT05333666 ·Status: RECRUITING
-
Adverse Drug Events in Patients on Oral Anticoagulation in the Emergency Department
NCT06692504 ·Status: RECRUITING
-
REduced Dose Versus Full-dose of Direct Oral Anticoagulant After uNprOvoked Venous thromboEmbolism.
NCT03285438 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Validation of a New Algorithm for Computerized Dosing of Vitamin K Antagonist Therapy
NCT01392040 ·Status: COMPLETED
-
Evaluataion of NOAC Levels in Acute Stroke
NCT06144866 ·Status: RECRUITING
-
Study of Clinical and Laboratory Variables Associated With a Direct Oral Anticoagulant Bioassay Higher Among Those Aged Over 75 Years
NCT02894450 ·Status: COMPLETED
-
Evaluation of Oral Anticoagulation With Vitamin K Antagonists - The thrombEVAL Study Programme
NCT01809015 ·Status: COMPLETED
-
Prevalence and Causes of Preventable and Serious Adverse Drug Reactions Related to the Use of Oral Anticoagulants
NCT02720328 ·Status: COMPLETED ·Phase: PHASE4
-
Registry of Patient With Antithrombotic Agents Admitted to an Emergency Department
NCT02706080 ·Status: UNKNOWN
-
Best Antithrombotic Therapy in Patients With Acute Venous ThromboEmbolism While Taking Antiplatelets
NCT05627375 ·Status: RECRUITING ·Phase: PHASE3
-
Efficacy of Direct Oral Anticoagulants as a Prophylactic Anticoagulation of Catheter Induced Thrombosis
NCT05705076 ·Status: UNKNOWN ·Phase: NA
-
Study of the Interest of Patients Undergoing Anti-thrombotic Treatment in a Digital Application of Therapeutic Assistance
NCT03968276 ·Status: TERMINATED ·Phase: NA
-
An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major Bleeding
NCT02319460 ·Status: COMPLETED
-
The Clinical and Economic Impact of Pharmacogenomic Testing of Warfarin Therapy in Typical Community Practice Settings
NCT00830570 ·Status: COMPLETED
-
Six Years of Follow-up After Idiopathic Venous Throbmoembolism
NCT02884934 ·Status: COMPLETED
-
Study in Healthy Volunteers of the Reversion by Haemostatic Drugs of the Anticoagulant Effect of New Anti-thrombotics
NCT01210755 ·Status: COMPLETED ·Phase: PHASE4
-
INR at Home Measurement by the LabPad® Point-of-care in Patients on Vitamin K Antagonist Drugs (VKA)
NCT04117048 ·Status: COMPLETED ·Phase: NA